CANbridge Pharmaceuticals Inc. (HK:1228) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
CANbridge Pharmaceuticals Inc. has announced a change of auditors, with Ernst & Young resigning due to disagreements over audit fees and HLB Hodgson Impey Cheng Limited stepping in as the new auditor. The company’s board believes this switch will aid in cost control and reduce operating expenses, ensuring the transition will not impact the annual results for 2024.
For further insights into HK:1228 stock, check out TipRanks’ Stock Analysis page.